| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | -0.042 | 0.8 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.8 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.8 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.019 | 0.8 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.0085 | 0.8 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.008 | 0.8 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.8 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.0072 | 0.8 |